Aphelion Capital

Aphelion Capital is a California-based venture capital firm focused on healthcare and technology. It invests in early- and mid-stage medical technology, medical devices, and digital health companies, prioritizing fast-to-market products that are low in capital intensity and that help reduce the cost of delivering quality healthcare. The firm leverages its networks to accelerate commercial success and to support portfolio companies across the United States. Founded in 2005, it operates with a view to building companies from inception through growth.

Kris Johnson

President

John Kim

Managing Director

Bob Mellen

Venture Partner

Ned Scheetz

Managing Partner

Lisa Suennen

Venture Partner

Robert Thomas

Venture Partner

Past deals in Wearables

Biolinq

Series C in 2025
Founded in 2012, Biolinq develops digital health platforms centered around skin-applied electronic biosensors. These minimally invasive sensors analyze biomarkers in interstitial fluid to provide real-time, actionable health information, initially focusing on continuous glucose monitoring for diabetic patients.

Biolinq

Venture Round in 2024
Founded in 2012, Biolinq develops digital health platforms centered around skin-applied electronic biosensors. These minimally invasive sensors analyze biomarkers in interstitial fluid to provide real-time, actionable health information, initially focusing on continuous glucose monitoring for diabetic patients.

Koya Medical

Venture Round in 2020
Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Biolinq

Series A in 2019
Founded in 2012, Biolinq develops digital health platforms centered around skin-applied electronic biosensors. These minimally invasive sensors analyze biomarkers in interstitial fluid to provide real-time, actionable health information, initially focusing on continuous glucose monitoring for diabetic patients.

iHear Medical

Debt Financing in 2017
iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

iHear Medical

Series C in 2017
iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

iHear Medical

Series C in 2016
iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

CyMedica

Series A in 2015
CyMedica Orthopedics, Inc. is a medical device company focused on developing and commercializing innovative products for joint injuries and the associated muscle atrophy. Founded in 2013 and based in Scottsdale, Arizona, CyMedica offers a range of orthopedic solutions that utilize proprietary neuromuscular electrical stimulation technology. Its flagship product, e-vive, provides individualized muscle stimulation therapy through a wireless and app-controlled system, allowing patients to engage in their rehabilitation while tracking progress and sharing data with clinicians. Additionally, the company offers a variety of products, including the Conductive garment, which ensures effective muscle activation, the ACL Brace for post-operative support, and The QB1 System, designed to empower patients in overcoming quadricep weakness. These devices aim to stabilize joints, prevent muscle weakening during recovery, and improve patient outcomes while reducing the likelihood of readmission.

iHear Medical

Series C in 2014
iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

VideoCare

Seed Round in 2013
VideoCare, Inc. is a technology company focused on enhancing connectivity between families and their aging loved ones through its innovative video communication solution. Founded in 2011 and based in Menlo Park, California, VideoCare offers a user-friendly touch-screen video system designed for elderly care recipients, eliminating the need for keyboards or technical skills. This system facilitates two-way video connections, allowing users to share photos, videos, and music, as well as track medication and appointments. VideoCare not only enables families to provide remote support and companionship but also assists professionals and care agencies in delivering care and maintaining communication with their clients. Through its technology, VideoCare aims to improve the quality of life for seniors by fostering meaningful connections with family and caregivers.

iHear Medical

Series A in 2010
iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.